» Articles » PMID: 14508784

Correlation of Dynamic Contrast Enhancement MRI Parameters with Microvessel Density and VEGF for Assessment of Angiogenesis in Breast Cancer

Overview
Date 2003 Sep 26
PMID 14508784
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate the association between parameters obtained from dynamic contrast enhanced MRI (DCE-MRI) of breast cancer using different analysis approaches, as well as their correlation with angiogenesis biomarkers (vascular endothelial growth factor and vessel density).

Materials And Methods: DCE-MRI results were obtained from 105 patients with breast cancer (108 lesions). Three analysis methods were applied: 1) whole tumor analysis, 2) regional hot-spot analysis, and 3) intratumor pixel-by-pixel analysis. Early enhancement intensities and fitted pharmacokinetic parameters were studied. Paraffin blocks of 71 surgically resected specimens were analyzed by immunohistochemical staining to measure microvessel counts (with CD31) and vascular endothelial growth factor (VEGF) expression levels.

Results: MRI parameters obtained from the three analysis methods showed significant correlations (P < 0.0001), but a substantial dispersion from the linear regression line was noted (r = 0.72-0.97). The entire region of interest (ROI) vs. pixel population analyses had a significantly higher association compared to the entire ROI vs. hot-spot analyses. Cancer specimens with high VEGF expression had significantly higher CD31 microvessel densities than did specimens with low VEGF levels (P < 0.005). No significant association was found between MRI parameters obtained from the three analysis strategies and IHC based measurements of angiogenesis.

Conclusion: A consistent analysis strategy was important in the DCE-MRI study. In this series, none of these strategies yielded results for MRI based quantitation of tumor vascularity that were associated with IHC based measurements. Therefore, different analyses could not account for the lack of association.

Citing Articles

The kinetic parameters of dynamic contrast-enhanced MRI with ultrafast imaging in breast cancer patients receiving neoadjuvant chemotherapy: Prediction of pathologic complete response and correlation with histologic microvessel density.

Choi S, Park A, Kim G, Jung H, Ko K, Kim Y Medicine (Baltimore). 2025; 104(5):e40239.

PMID: 39889156 PMC: 11789864. DOI: 10.1097/MD.0000000000040239.


Multiparametric MRI-based radiomic nomogram for predicting HER-2 2+ status of breast cancer.

Wang H, Sang L, Xu J, Huang C, Huang Z Heliyon. 2024; 10(9):e29875.

PMID: 38720718 PMC: 11076642. DOI: 10.1016/j.heliyon.2024.e29875.


Microvascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer.

Borretzen A, Reisaeter L, Ringheim A, Gravdal K, Haukaas S, Fasmer K Sci Rep. 2023; 13(1):17949.

PMID: 37863961 PMC: 10589248. DOI: 10.1038/s41598-023-45158-4.


Vascularity and Dynamic Contrast-Enhanced Breast Magnetic Resonance Imaging.

Frankhouser D, Dietze E, Mahabal A, Seewaldt V Front Radiol. 2023; 1:735567.

PMID: 37492179 PMC: 10364989. DOI: 10.3389/fradi.2021.735567.


PET/MRI of hypoxia and vascular function in ER-positive breast cancer: correlations with immunohistochemistry.

Carmona-Bozo J, Manavaki R, Miller J, Brodie C, Caraco C, Woitek R Eur Radiol. 2023; 33(9):6168-6178.

PMID: 37166494 PMC: 10415421. DOI: 10.1007/s00330-023-09572-6.